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Endoscopic stenting with a self-expandable metallic stent (SEMS) is widely accepted for the management of malignant colorectal obstruction (MCRO).
This procedure is effective for both palliative purposes and as a bridge to surgery. MCRO can arise from colorectal cancer (CRC) or advanced extracolonic
malignancy (ECM), including gastric, pancreatobiliary, small bowel, endometrial gynecologic, or urinary malignancies. In patients with an ECM, the
pathogenesis of obstruction is different from that of CRC and is caused by direct tumor invasion into the lumen or extrinsic compression at an advanced
stage. These differences and the advanced clinical condition can inﬂuence the clinical results. Endoscopic colonic stenting for ECM has lower technical and
clinical success rates than for CRC. Appropriate patient selection and technical issues are key to improved outcomes. In the near future, a prospective
clinical trial should evaluate the efﬁcacy and safety of SEMS placement for MCRO caused by ECM.
Copyright  2014, Society of Gastrointestinal Intervention. Published by Elsevier. All rights reserved.
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Acute colorectal obstruction causes symptoms such as nausea,
vomiting, abdominal pain, distention, and altered bowel habits, and
results in bowel dilation and ﬂuid retention. Perfusion to the in-
testine can be compromised, leading to necrosis, dehydration, or
perforationdcomplications that increase the mortality rate. Ma-
lignancy is the most common cause of colorectal obstruction,
causing 90% of cases.1 Malignant colorectal obstruction (MCRO)
generally requires rapid bowel decompression, such as emergency
surgery, which is associated with high mortality and morbidity.2,3
Since its introduction for treating MCRO in 1991,4 endoscopic
stenting with self-expandable metallic stents (SEMSs) has become
widely accepted for the palliative management of malignant
colonic obstruction and as a bridge to surgery.5–8 Given its low
invasiveness, this procedure is an option, along with bypass surgery
or colostomy, for patients with unresectable colonic obstructions.9
MCRO can also occur in patients with an extracolonic malig-
nancy (ECM), such as gastric, pancreatobiliary, urogenital, and gy-
necologic malignancies.10,11 Accumulated evidence has shown that
SEMS placement is an acceptable alternative to surgery for man-
aging MCRO caused by colorectal cancer (CRC). Although the ob-
structions in CRC are caused by intraluminal growth, those in ECM
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The tumor ﬁxes the stricture site, which loses its ﬂexibility. In
addition, intestinal peristalsis can be blocked by adhesions after a
previous operation, radiation, or carcinomatosis from the primary
lesion. These conditions make it difﬁcult to insert a colonoscope, to
traverse the stricture, and to insert the SEMS. In comparison with
CRC, bowel obstruction caused by ECM tends to cause a complex
stricture, potentially at more than one location. Therefore, access-
ing or traversing a stricture caused by ECM is more difﬁcult than for
those resulting from CRC.
Emergency surgery performed on acutely ill patients with large-
bowel obstruction due to malignancy, which includes bypasses,
resection, and colostomy, has a 16–23% morbidity rate and a 5–20%
mortality rate.12–14 Palliative surgery for MCRO caused by ECM is
also associated with signiﬁcant morbidity.15,16 Evenwith successful
surgery, many patients require a colostomy or ileostomy. The stoma
has signiﬁcant morbidity and reduces the quality of life over the
short- and long-term.17 Given the low invasiveness of SEMS
placement, it is an effective alternative for resolving MCRO caused
by ECM.
Until 2000, few patients with colorectal obstruction due to ECM
had undergone SEMS placement for palliation.14,18 In most of these
early studies, colonic obstruction from ECM was included in ma-
lignant colonic obstruction and was not distinguished from that ofersity of Tokyo, Tokyo, Japan
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published with advances in endoscopic techniques and SEMS
technology.10,19–33 Ten years have passed since a pooled analysis
reported that the technical failure rate was higher in patients with
ECM versus primary CRC5; to date, the availability and safety of this
procedure have not been determined sufﬁciently.
This paper reviews the treatment forMCRO caused by ECM,with
emphasis on SEMS placement.
Indications and practical considerations
As with CRC, SEMS placement is contraindicated in patients
with enteral ischemia, suspected or impending perforation, mul-
tiple small-bowel site involvement, other synchronous colonic
obstruction, or intra-abdominal abscess/perforation.
Typically, acute colonic obstruction is symptomatic. Abdominal
x-rays show a dilated colon and colonoscopy shows an obstruction
caused by an intra- or extraluminal lesion. To evaluate the cause
and location of the obstruction, computed tomography (CT) with/
without a contrast agent, colonoscopy, and barium enema or
enema with water-soluble contrast material could be performed.
Kim et al32 reported that CT combined with a barium enema was
useful for evaluating the number and length of strictures. Magnetic
resonance imaging is also useful for ruling out a ﬁstula between the
intestine and uterus or bladder.
The obstruction with an ECM often involves the left colon or
rectum (Table 1). Although it can be more difﬁcult to insert a SEMS
for an obstruction proximal to the splenic ﬂexure,34 recent articles
report the effectiveness and safety of SEMS placement for a prox-
imal obstruction in ECM.26,30,33 Improvements in endoscopy,
guidewires, and stents have increased the indications for treating
proximal obstructions of the colon caused by an ECM.
Although multiple strictures typically rule out SEMS placement,
some authors have reported simultaneous SEMS placement at two
different obstruction sites.10,22,26,32 Kim et al30 reported better
clinical outcomes for SEMS placement for patients with one or two
obstructions versus multiple obstructions. After a careful pre-
procedural examination, including high-resolution CT, barium, or
water-soluble enema images, we think one can insert a SEMS for
one or two obstructions.Table 1 Self-expandable Metallic Stent (SEMS) Placement for an Extracolonic Malig
Author YearRef Patients (n) Covered Including
gastric cancer (%)
Miyayama et al 200019 8 Uncovered and
covered
Y (25)
Law et al 200035 11 Uncovered Y (45)
Carter et al 200221 2 Uncovered N
Pothuri et al 200410 6 Uncovered N
Watson et al 200522 13 Uncovered Y (8)
Sherazi et al 200623 1 Uncovered N
Caceres et al 200824 35 Uncovered N
Baraza et al 200825 7 Uncovered and
covered
Y (14)
Shin et al 200826 39 Uncovered and
covered
Y (79)
Keswani et al 200927 15 Uncovered Y (7)
Trompetas et al 201028 12 NA N
Yoon et al 201129 114 Uncovered and
covered
Y (72)
Kim et al 201230 111 Uncovered and
covered
Y (100)
Keranen et al 201231 24 Uncovered Y (17)
Kim et al 201332 20 Uncovered and
covered
Y (70)
Moon et al 201433 44 Uncovered Y (59)
CT, computed tomography; MRI, magnetic resonance imaging; N, no; NA, not available;The etiology of ECM includes metastases and carcinomatosis
from gastrointestinal, pancreatobiliary, urogenital, and gynecolog-
ical malignancies. It is not clear whether it includes recurrent CRC.
Some authors report SEMS placement for EMC that includes
recurrent CRC.19,35 It seems reasonable to include it when CT
identiﬁes disseminated or recurrent CRC as the cause of the
obstruction resulting from extraluminal compression. Kim et al30
found that SEMS placement was less effective than emergency
surgery for palliation of colorectal obstruction in patients with
advanced gastric cancer, although there are differences based on
the primary disease, dominant pattern of obstruction (e.g., extrinsic
compression, adhesion, or tumor inﬁltration), or location of
obstruction (e.g., upper abdominal cavity or pelvic cavity).
In some cases, MCRO due to ECM did not improve after colonic
stenting. Those patients had multiple stenoses, intestinal stenosis,
impaired bowelmovement, or impaired digestive tract motility due
to an omental cake. The patient and tumor status should be eval-
uated carefully before deciding to stent a MCRO due to ECM.SEMS placement procedures
There are two main techniques for SEMS placement for colo-
rectal obstruction: radiological placement under ﬂuoroscopic
guidance only and combined endoscopic/ﬂuoroscopic placement.36
When using endoscopic/ﬂuoroscopic placement, if the system
cannot pass through the working channel of the endoscope, the
endoscope must be removed after the guidewire is placed and
SEMS insertion is performed under ﬂuoroscopic guidance. If
desired, the endoscope can be reintroduced into the colon beside
the stent catheter to visualize the precise position of the stent.
Although there are no prospective or controlled data, the available
data appear to show no difference in the success rates of the two
SEMS placement techniques for ECM (Table 1). Difﬁculty with SEMS
placement for colorectal obstruction results from the impossibility
of either negotiating the entire stricture with a guidewire or
passing the long, tortuous colon. In some cases, direct visualization
and stability of stent insertion with an endoscope might be more
helpful.
The endoscopic/ﬂuoroscopic placement procedure is as follows.
Awideworking channel endoscope is introduced to the obstructionnancy (ECM)
Including
carcinomatosis
CT, MRI, or
contrast enema
Endoscopic/
ﬂuoroscopic placement
TS (%) CS (%)
Y Y N 100 88
Y N Y 100 100
N Y Y 100 100
NA Y Y 100 67
NA N N 85 62
Y Y N 100 100
NA Y Y 77 51
NA NA Y 85 57
Y Y Y 87 82
Y Y Y 67 20
Y NA N 42 25
Y Y Y 81 84
Y Y Y 74 54
Y Y Y 96 65
Y Y Y 90 85
Y Y Y 93 77
TS, technical success; CS, clinical success; Y, yes.
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obstruction is identiﬁed in the endoscopic image or delineatedwith
contrast medium. An angiographic catheter, biliary catheter,
sphincterotome, or balloon catheter preloaded with a hydrophilic
0.035-inch biliary guidewire is used to traverse the stricture under
ﬂuoroscopic guidance until a safety loop of the guidewire is created
proximal to the stricture. ECM strictures tend to be longer than CRC
strictures.27,31 It becomes more important to negotiate the stricture
and to measure its exact length. A water-soluble contrast agent is
injected into the proximal side of the stricture to assess stricture
length. A balloon catheter can also be used tomeasure the length of
the stricture.31 The appropriate length of the stent is determined by
adding 2–5 cm to the length of the stricture. The delivery system is
advanced through the working channel over the guidewire and is
guided ﬂuoroscopically into the site of obstruction. The middle of
the stent is adjusted at the narrowest site of the stricture, while the
outer sheath is retracted under ﬂuoroscopic and endoscopic
guidance.
Balloon dilation of the stricture is performed before or after
stent placement (Fig. 1), when the delivery system cannot pass
through the stricture or the expansion of the stent is unsatisfac-
tory.10,19,24,29,31 Although prestenting dilation with a balloon cath-
eter has been related to colonic perforation in experimental37 and
clinical38 studies of CRC, we found no relationship between balloon
dilation before or afterwards and perforation. Only in colorectal
obstruction caused by ECM is it permitted to perform balloon
dilation before or afterwards, when the patient does not haveFig. 1. Endoscopic balloon dilation after WallFlexTM Colonic Stent (made by Boston Sciedeﬁnite luminal mucosal changes caused by the direct inﬁltration
of malignant cells.
We often cannot deﬁne the spread of the tumor along the colon
in disseminating cases. In these cases, we check the length of the
narrowing on both sides of the tumor; a SEMS with sufﬁcient
length to cover the narrowed portion should be selected. If the
stricture is located at the splenic/hepatic ﬂexure or in another
acutely angled area, a braided-type SEMS, such as the WALLSTENT
(Boston Scientiﬁc, Natick, MA), should be avoided. A braided SEMS
might not expand and could kink in a stricture in an acutely angled
portion of the bowel (Fig. 1); knitted-type SEMS like the Niti-S
(Taewoong, Inc., Gimpo, South Korea) stent can overcome this
problem.
Clinical outcomes
To date, more than 400 cases of SEMS placement for colorectal
obstruction caused by an ECM have been described in 16 reports.
Twelve groups preferred endoscopic/ﬂuoroscopic placement, and
four groups used radiological placement.
The technical success rate was 88.5% (range 67–100%) in the 12
articles reporting more than one endoscopic/radiological place-
ment. Radiological placement was reported to be technically suc-
cessful in 92.5% (range 42–100%). There seems to be no difference
according to the procedure (radiological or endoscopic/ﬂuoro-
scopic), location in the colon (right and left side), or etiology
(gastric or nongastric).ntiﬁc Corporation (Natick, MA 01760-1537)) placement with insufﬁcient expansion.
Gastrointestinal Intervention 2014 3(2), 75–7978The clinical success rate was 72.2% (range 20–100%) in the 12
articles reporting more than one endoscopic/radiological place-
ment. Radiological placement was reported to be clinically suc-
cessful in 75% (range 20–100%). There was also no difference in
terms of the procedure, location, or etiology.
Complications
The most common complication is reobstruction of the SEMS
due to tumor ingrowth (Table 2). This complication can be resolved
by placing an additional SEMS using stent-in-stent techniques or by
surgery. Given the etiology of ECM, obstruction at another site can
also occur. When obstruction symptoms recur, the possible causes
of the patient’s symptoms must be reassessed using CT or a barium
or water-soluble enema. Although secondary stent-in-stent SEMS
placement for MCRO is a promising way to resolve the symptoms,39
it is reasonable to perform this procedure in patients who are not
candidates for surgery. The use of a covered SEMS is not favored as
ﬁrst-line therapy because of the high rate of migration. For sec-
ondary intervention for an occluded SEMS due to tumor ingrowth,
however, a covered SEMS is a promising option for managing tumor
invasion via the stent mesh. In such situations, the risk of migration
is relatively low.
Sometimes, the SEMS becomes kinked and does not dilate in an
acutely angled portion of the bowel, such as the splenic or hepatic
ﬂexure (Fig. 1). This complication can occur with a braided-type
SEMS, such as the WALLSTENT, but not with a knitted-type SEMS,
such as the Niti-S. We can manage this situation with balloon
dilation or additional stent-in-stent placement.
Stent migration was the second most common complication. In
general, migration is caused by misplacement, inadequate stent
length, placement for incomplete obstruction, or soft tumor tissue.
Late stent migration might be related to tumor shrinkage caused by
chemotherapy after SEMS placement. A covered SEMS is regarded
as superior at preventing tumor ingrowth, but inferior at prevent-
ing stent migration in MCRO, because the stent is less embedded in
the lumen wall compared with uncovered stents.40 Because the
ECM obstruction is caused by both direct tumor invasion and
extrinsic compression, adhesions, and decreased peristalsis, it is
assumed that the migration rate of SEMS placed for ECM is high,
although no prospective, randomized study has examined this
issue.
Future directions
In this review, SEMS placement for MCRO due to an ECM was
shown to be an appealing option in patients who are deemed poorTable 2 Complications of Colorectal Stenting for Colorectal Obstruction by an
Extracolonic Malignancy (ECM)
Reference Patients
(n)
Bleeding
(n)
Migration
(n)
Perforation
(n)
Obstruction
(n)
Miyayama et al19 8 2 1
Law et al35 11 2 3
Carter et al21 2
Pothuri et al10 6 1
Watson et al22 13
Sherazi et al23 1
Caceres et al24 35 1 1
Baraza et al25 7 1
Shin et al26 39 5 14
Keswani et al27 15 2 2
Trompetas et al28 12 1
Yoon et al29 114
Kim et al30 111 3 8 8 34
Keranen et al31 24 1 2 3
Kim et al32 20 1 5
Moon et al33 44 10 2 3surgical candidates. Relative to surgery, stent placement allows a
more rapid return to functional intestinal status, with a shorter
hospital stay; as a result, the early induction of chemotherapy is
possible for patients who need palliative chemotherapy. However,
stent insertion for MCRO with ECM is technically challenging and
accompanied by complications. A careful preoperative examination
of multiple strictures is necessary when selecting candidates for
SEMS placement. When considering SEMS for MCRO with an ECM,
it might be best to exclude patients with three or more colonic
strictures. It is necessary to compare the efﬁcacy and safety of SEMS
for MCRO with ECM with surgery in a prospective, randomized
study. The development of new endoscopes, devices to traverse the
stricture, and novel highly ﬂexible stents will facilitate SEMS
placement for colorectal obstruction with an ECM.
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